Saturday 17 October 2026
Export ONMD’s income statement to Excel — free account
OneMedNet Corporation
ONMD Healthcare Health Information Services
OneMedNet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 million, up 111.4% from fiscal 2024. In the quarter to June 2026, revenue grew 88.4%, EPS fell 148.2%, free cash flow grew 14.1% and total debt rose 75.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
4.51
0.24
−5.05%
Follow ONMD
| Dec '17 | Jan '21 | Dec '21 | Jan '22 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | — | 4 | 4 |
P/E ratio |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | — | (104.52) | (357.02) | (50.35) | (77.91) |
P/S ratio |
— | — | — | — | 0.00 | 5.28 | 59.39 | 36.06 |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | (317.91) | (933.19) | (134.49) | (197.32) |
P/FCF ratio |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | — | — | (10.62) | (3.12) | (19.13) | (28.61) |
P/B ratio |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | — | — | — | 0.00 | 9.07 | 63.06 | 35.97 |
EV/EBITDA |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | (9.08) | (1.93) | (5.83) | (6.52) |
EV/FCF |
— | — | — | — | (9.08) | (1.89) | (5.79) | (6.50) |
Quick Ratio |
— | 1.56 | 1.56 | 0.02 | 0.01 | 0.01 | 0.17 | 0.33 |
Current Ratio |
— | 1.85 | 1.85 | 0.02 | 0.02 | 0.03 | 0.19 | 0.43 |
Net Debt/EBITDA |
— | 0.77 | 0.77 | 0.01 | (0.16) | (0.50) | (0.06) | 0.01 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 116.37% | 745.04% | 96.81% | 45.28% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | (0.06) | (0.26) | (0.23) | (0.33) |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.02 | 1.16 | 0.31 | 0.46 |
Operating CF/Net income |
— | (0.07) | (0.07) | (2.79) | 0.15 | 0.14 | 0.69 | 2.68 |
Capex/Depreciation |
— | — | — | — | (2.32) | (1.57) | (0.89) | (0.20) |
Interest Coverage |
— | (616.21) | — | — | (19.13) | (623.00) | (65.34) | (144.28) |
| — | 10.26% | 10.26% | 0.00% | 115.76% | 117.61% | 68.92% | 29.62% | |
| — | 8.72% | 4.36% | 0.00% | (51.12%) | (3,853.96%) | (483.37%) | (95.30%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
— | 2,086.03% | 2,086.03% | (17.31%) | 118.81% | 252.58% | 65.34% | 104.75% |
Average Days of Receivables |
— | — | — | — | 6.01 | 54.34 | 120.91 | 132.95 |
Research and Development Expense of Revenue |
— | — | — | — | 137.99% | 202.25% | 228.15% | 111.48% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | — | 0.00% | 499.91% | 456.32% | 1,221.93% | 562.84% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | — | — | 161.75% | 144.47% | 97.67% | 149.52% |
Graham Net Nets |
— | — | — | — | (0.66) | (2.51) | (0.42) | (0.06) |
Graham Number |
— | — | — | — | 444.51 | 139.01 | 19.66 | 3.07 |
Earnings Yield |
— | — | — | — | (75.97%) | (626.97%) | (22.24%) | (5.72%) |
Free Cash Flow Yield |
— | — | — | — | (11.34%) | (90.82%) | (18.34%) | (15.34%) |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 2.90 | 1.40 | 0.23 | 0.31 |
Operating CF per Share |
— | (0.03) | (1.15) | (0.08) | (11.83) | (6.59) | (2.48) | (1.68) |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | (0.15) | (0.06) | (0.02) | 0.00 |
Free Cash Flow per Share |
— | (0.03) | (1.15) | (0.08) | (11.98) | (6.65) | (2.49) | (1.69) |
Cash per Share |
— | 0.03 | 1.38 | 0.00 | 0.68 | 0.06 | 1.08 | 0.24 |
Shareholders Equity per Share |
— | 7.27 | (26.12) | 1.64 | (66.33) | (18.49) | (5.68) | (0.67) |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 7.27 | (26.12) | 1.64 | (66.33) | (18.49) | (5.68) | (0.67) |
Free Cash Flow |
— | (0.38) | (0.38) | (0.94) | (4.76) | (4.83) | (7.00) | (7.52) |
Working Capital |
— | 0.25 | 0.25 | (1.95) | (25.71) | (13.47) | (15.61) | (2.73) |
Capital Expenditures |
— | — | — | — | (0.06) | (0.04) | (0.05) | (0.01) |
Net Current Asset Value |
— | (8.63) | (125.93) | (9.09) | (27.26) | (13.54) | (16.06) | (3.02) |
EV/EBIT |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | — | — | — | 0.05 | 0.04 | 0.08 | 0.01 |
Price to Operating Income |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | — | — | — | 0.30 | 0.28 | 0.53 | 1.16 |
Cash ROIC |
— | (0.35%) | 4.64% | (4.71%) | 19.36% | 48.65% | 75.13% | 835.11% |
Accounts Receivable Turnover |
— | — | — | — | 0.00 | 11.94 | 3.52 | 3.84 |
Accounts Payable Turnover |
— | — | — | — | 0.00 | 0.39 | 0.17 | 0.39 |
Inventory Turnover |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | — | — | — | 283.94 | 1,486.03 | 2,385.14 | 685.31 |
Days of Inventory on Hand |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | — | — | — | 0.09 | 0.18 | 0.35 |
Average Payables |
— | — | — | — | — | 2.93 | 5.36 | 4.77 |
Average Assets |
— | 58.93 | 117.86 | 73.46 | 59.57 | 0.88 | 2.10 | 2.94 |
Average Common Equity |
— | 50.04 | 50.04 | 5.67 | (26.31) | (28.72) | (14.70) | (9.46) |
Columns are period end dates · fundamentals updated 2 Oct 2026